Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Interventional × Oesophagogastric Cancer × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 178 Neoplasms 97 Colorectal Neoplasms 84 Stomach Neoplasms 76 Uterine Cervical Neoplasms 66 Carcinoma, Non-Small-Cell Lung 63 Carcinoma, Hepatocellular 49 Prostatic Neoplasms 44 Lung Neoplasms 44 Rectal Neoplasms 43 Esophageal Neoplasms 34 Pancreatic Neoplasms 32 Ovarian Neoplasms 32 Head and Neck Neoplasms 31 Colonic Neoplasms 30 Recurrence 28 Motor Activity 28 Neoplasm Metastasis 26 Polycystic Ovary Syndrome 24 Small Cell Lung Carcinoma 23 Lymphoma, Non-Hodgkin 23 Lymphoma 23 Multiple Myeloma 22 Melanoma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Leukemia, Myeloid, Acute 20 Pain 19 Nasopharyngeal Carcinoma 18 Fallopian Tube Neoplasms 17 Brain Neoplasms 17

Interventions

Neoadjuvant Therapy 1 Lapatinib 1 Epirubicin 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00450203 2016-12-01

ST03

Medical Research Council

Phase 2/3 Unknown

Gastrointestinal

Oesophagogastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡